Realistic depiction of sticky mitochondrial DNA damage (glutathionylated adducts) disrupting cell energy, activating stress pathways, and linking to diseases like diabetes, cancer, and neurodegeneration.
Immagine generata dall'IA

Researchers identify sticky mitochondrial DNA damage tied to cellular stress and disease risk

Immagine generata dall'IA
Verificato

Scientists at the University of California, Riverside have identified a previously unknown form of mitochondrial DNA damage known as glutathionylated DNA adducts, which build up at dramatically higher levels in mitochondrial DNA than in nuclear DNA. The lesions disrupt energy production and activate stress-response pathways, and researchers say the work could help explain how damaged mitochondrial DNA contributes to inflammation and diseases including diabetes, cancer and neurodegeneration.

Mitochondria, the cell's energy producers, contain their own genetic material known as mitochondrial DNA (mtDNA), which accounts for roughly 1–5% of a cell's total DNA. Unlike nuclear DNA (nDNA), mtDNA is circular, carries 37 genes, and is inherited exclusively from the mother, while nDNA is linear and passed down from both parents.

Scientists have long known that mtDNA is prone to damage, but the biological details have been unclear. A UC Riverside-led study now pinpoints a specific culprit: glutathionylated DNA (GSH-DNA) adducts, a newly identified, "sticky" form of DNA damage that forms when a chemical group attaches directly to the DNA.

In experiments using cultured human cells, the research team found that these bulky chemical attachments accumulate in mtDNA at levels up to 80 times higher than in nuclear DNA, underscoring mtDNA's particular vulnerability to this type of injury. The work was led by Linlin Zhao, an associate professor of chemistry at UC Riverside, and is described in the Proceedings of the National Academy of Sciences.

"mtDNA is more prone to damage than nDNA," Zhao said in a UC Riverside news release. "Each mitochondrion has many copies of mtDNA, which provides some backup protection. The repair systems for mtDNA are not as strong or efficient as those for nuclear DNA."

The team linked the buildup of GSH-DNA adducts to marked changes in mitochondrial function. As the sticky lesions accumulate, proteins required for energy production decline, while proteins involved in stress responses and mitochondrial repair increase, indicating that cells attempt to counteract the damage.

The researchers also used advanced computer simulations to probe how the adducts alter the physical properties of mtDNA. The models suggested that the added chemical tags make the mitochondrial genome less flexible and more rigid, a change that may help mark damaged DNA for disposal so it is not copied and passed on.

Yu Hsuan Chen, the study's first author and a doctoral student in Zhao's laboratory, compared the problem to a damaged instruction manual inside an engine.

"When the engine's manual — the mtDNA — gets damaged, it's not always by a spelling mistake, a mutation," Chen said. "Sometimes, it's more like a sticky note that gets stuck to the pages, making it hard to read and use. That's what these GSH-DNA adducts are doing."

According to Zhao, the discovery of GSH-DNA adducts offers a new way to investigate how damaged mtDNA can act as a stress signal inside the body and potentially contribute to disease.

"Problems with mitochondria and inflammation linked to damaged mtDNA have been connected to diseases such as neurodegeneration and diabetes," Zhao said. "When mtDNA is damaged, it can escape from the mitochondria and trigger immune and inflammatory responses. The new type of mtDNA modification we've discovered could open new research directions to understand how it influences immune activity and inflammation."

The study, which also has implications for conditions such as cancer that are associated with mitochondrial dysfunction, was carried out by researchers at UC Riverside and the University of Texas MD Anderson Cancer Center. It was funded by grants from the National Institutes of Health and UC Riverside.

The findings appear in the journal Proceedings of the National Academy of Sciences in a paper titled "Glutathionylated DNA adducts accumulate in mitochondrial DNA and are regulated by AP endonuclease 1 and tyrosyl-DNA phosphodiesterase 1."

Articoli correlati

Illustration of a scientist studying a mouse brain model on a screen, highlighting astrocyte mitochondrial free radicals linked to dementia research.
Immagine generata dall'IA

Astrocyte mitochondrial free radicals tied to dementia pathology in mice

Riportato dall'IA Immagine generata dall'IA Verificato

Weill Cornell Medicine researchers report that free radicals generated at a specific mitochondrial site in astrocytes appear to promote neuroinflammation and neuronal injury in mouse models. Blocking those radicals with tailored compounds curbed inflammation and protected neurons. The findings, published Nov. 4, 2025, in Nature Metabolism, point to a targeted approach that could inform therapies for Alzheimer’s disease and frontotemporal dementia.

Researchers at the University of Technology Sydney have created experimental compounds that prompt mitochondria to burn more calories safely. These mild mitochondrial uncouplers could offer a new approach to treating obesity without the deadly risks of past chemicals. The findings, published in Chemical Science, highlight potential benefits for metabolic health and aging.

Riportato dall'IA

Researchers at the University of California, Riverside, have identified how inflammation in multiple sclerosis disrupts mitochondrial function in the brain, leading to the loss of key neurons that control balance and coordination. Published in the Proceedings of the National Academy of Sciences, the findings highlight a potential pathway for new treatments to preserve mobility in the 2.3 million people affected by the disease worldwide. The study examined human brain tissue and a mouse model to trace these energy failures over time.

Researchers at The Rockefeller University have identified a molecular switch in breast cancer cells that helps them survive harsh conditions. The switch involves deacetylation of the MED1 protein, which boosts stress-response gene activity linked to tumor growth and resilience. The work, reported in Nature Chemical Biology, points to potential new targets for cancer therapy.

Riportato dall'IA

New research from MIT demonstrates that prolonged high-fat diets push liver cells into a primitive state, increasing their vulnerability to cancer. By analyzing mice and human samples, scientists uncovered how these cellular changes prioritize survival over normal function, paving the way for tumors. The findings, published in Cell, highlight potential drug targets to mitigate this risk.

A new genetic study has identified 331 genes essential for transforming stem cells into brain cells, including a novel gene linked to neurodevelopmental disorders. Led by scientists at the Hebrew University of Jerusalem, the research highlights how early genetic disruptions can lead to conditions like autism and developmental delay. The findings, published in Nature Neuroscience, also reveal patterns in how these disorders are inherited.

Riportato dall'IA Verificato

Scientists have identified a genetic modifier that helps cells cope with the loss of frataxin, the protein at the core of Friedreich’s ataxia. By lowering activity of the FDX2 gene, experiments in worms, human cells, and mice showed that key energy‑producing processes can be restored, pointing to a potential new treatment strategy.

 

 

 

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta